JNJ vs ZBH
By Alex · Tickerpine
Johnson & Johnson vs Zimmer Biomet Holdings, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | ZBH |
|---|---|---|
| Price | $254.66 | $93.10 |
| Market cap | $613.02B | $18.01B |
| P/E ratio | 29.5 | 24.1 |
| ROE | 26.42% | 6.07% |
| Profit margin | 21.83% | 9.05% |
| Revenue growth | 9.90% | 9.30% |
| Dividend yield | 2.10% | 1.03% |
| Beta | 0.26 | 0.47 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs ZBH in plain English
- JNJ is the bigger company — about 34.0× the market cap of ZBH.
- ZBH is cheaper on earnings (P/E 24.1 vs 29.5).
- JNJ earns a higher return on equity (26% vs 6%).
- JNJ is growing revenue faster (10% vs 9%).
- JNJ has the higher dividend yield (2.10% vs 1.03%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
ZBH return calculator
See what $1,000 in Zimmer Biomet Holdings, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.